Pseudomonas aeruginosa PfpI is a methylglyoxalase.
     
          L Grimm, A Wijaya, I Askenasy, RR Nazeer, H Seki, PD Brear, W Figueroa, DR Spring, M Welch  
  
          – Journal of Biological Chemistry  
  
          (2025)  
  
          301,   
  
    
    
            
  
     
      
      
          The 2-methylcitrate cycle and the glyoxylate shunt in Pseudomonas aeruginosa are linked through enzymatic redundancy
     
          AJ Wijaya, SK Dolan, M Kohlstedt, L Gläser, P Brear, S Geddis, C Wittmann, DR Spring, M Welch  
  
          – J Biol Chem  
  
          (2025)  
  
          301,   
  
    
    
            
  
     
      
      
          Development of D-box peptides to inhibit the Anaphase Promoting Complex/Cyclosome
     
          R Eapen, C Okoye, C Stubbs, M Schimpl, T Tischer, E McCall, M Zacharopoulou, F Ferrer, D Barford, D Spring, C Lindon, C Phillips, LS Itzhaki  
  
            
  
          (2025)  
  
            
  
    
    
            
  
            
   
      
      
          Advances in the Release of Amide‐Containing Molecules
     
          T Wharton, DR Spring  
  
          – Chemistry (Weinheim an der Bergstrasse, Germany)  
  
          (2025)  
  
          31,   
  
    
    
            
  
            
   
      
      
          Correction to: Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2)
     
          H-C Chen, N Mueller, K Stott, C Kapeni, E Rivers, CM Sauer, F Beke, SJ Walsh, N Ashman, L O'Brien, A Rafati Fard, A Ghodsinia, C Li, F Joud, O Giger, I Zlobec, I Olan, SJ Aitken, M Hoare, R Mair, E Serrao, JD Brenton, A Garcia-Gimenez, SE Richardson, B Huntly, DR Spring, M-O Skjoedt, K Skjødt, M de la Roche, M de la Roche  
  
          – EMBO Molecular Medicine  
  
          (2024)  
  
          16,   
  
    
    
            
  
            
   
      
      
          Selective Aurora A-TPX2 Interaction Inhibitors Have In Vivo Efficacy as Targeted Antimitotic Agents
     
          SR Stockwell, DE Scott, G Fischer, E Guarino, TPC Rooney, T-S Feng, T Moschetti, R Srinivasan, E Alza, A Asteian, C Dagostin, A Alcaide, M Rocaboy, B Blaszczyk, A Higueruelo, X Wang, M Rossmann, TR Perrior, TL Blundell, DR Spring, G McKenzie, C Abell, J Skidmore, AR Venkitaraman, M Hyvönen  
  
          – J Med Chem  
  
          (2024)  
  
          67,   
  
    
    
            
  
            
   
      
      
          Novel immunotherapeutics against LGR5 to target multiple cancer types
     
          H-C Chen, N Mueller, K Stott, C Kapeni, E Rivers, CM Sauer, F Beke, SJ Walsh, N Ashman, L O'Brien, A Rafati Fard, A Ghodsinia, C Li, F Joud, O Giger, I Zlobec, I Olan, SJ Aitken, M Hoare, R Mair, E Serrao, JD Brenton, A Garcia-Gimenez, SE Richardson, B Huntly, DR Spring, M-O Skjoedt, K Skjødt, M de la Roche, M de la Roche  
  
          – EMBO Molecular Medicine  
  
          (2024)  
  
          16,   
  
    
    
            
  
            
   
      
      
          Tuneable thiol exchange linkers for traceless drug release applications in prodrugs and ADCs
     
          R Walther, M Park, N Ashman, M Welch, JS Carroll, DR Spring  
  
          – Chem Commun (Camb)  
  
          (2024)  
  
          60,   
  
    
    
            
  
     
      
      
          Towards the Targeted Protein Degradation of PRMT1
     
          PL Martin, FJ Pérez-Areales, SV Rao, SJ Walsh, JS Carroll, DR Spring  
  
          – Chemmedchem  
  
          (2024)  
  
          19,   
  
    
    
            
  
            
   
      
      
          Photoredox C(2)-Arylation of Indole- and Tryptophan-Containing Biomolecules.
     
          BM da S Santos, FG Finelli, DR Spring  
  
          – Organic Letters  
  
          (2024)  
  
          26,